Global Ophthalmic Drug & Devices Market to Grow at 5.97% of CAGR by 2026

“Global ophthalmic drug & devices market was valued nearly $58900 million in 2017 and is anticipated to reach $98700 million by 2027, growing at an estimated CAGR of 5.97% during the forecast period of 2018-2026.”
According to a new market research report launched by Inkwood Research, the Global ophthalmic drug & devices market was valued nearly $58900 million in 2017 and is anticipated to reach $98700 million by 2027, growing at an estimated CAGR of 5.97% during the forecast period of 2018-2026.

Browse 40 market data tables and 40 figures spread over 250 pages along with in-depth analysis on Global ophthalmic drug & devices marketby Ophthalmic Devices (Diagnostic & Monitoring Equipment, Surgery Device) by Vision Care (Contact Lens, Spectacles, Eye Exams) by Ophthalmic Drugs ( by Prescription Type, by Drug Delivery Types, by Type of Disease, by Therapeutics) by End User(Hospitals, Eye Clinics, Diagnostic Centers, Patients) & Geography

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing significant geographies such as North America, Europe, Asia Pacific, and Rest of World, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.

 

Global ophthalmic drug & devices market scenario

 

Global increase in prevalence rates of eye disease, increasing prevalence of diabetes increases probability of ophthalmic disorders, increasing geriatric population globally, technological advancement, increase in healthcare expenditure are the factors influencing the growth of ophthalmic drug & devices market across the globe.

The ophthalmic drug & devices market report provides data tables and includes charts and graphs for visual analysis.

Request Free Sample Report for ophthalmic drug & devices Market by Ophthalmic Devices, Vision Care, Ophthalmic Drugs, End-User and Geography: https://www.inkwoodresearch.com/reports/global-opthalmology-drugs-and-devices-market/#request-free-sample

  Market Segmentation

On the basis of Ophthalmic Devices, the ophthalmic drug & devices market is segmented into:

  • Diagnostic & Monitoring Equipment
  • Surgery Device

On the basis of Vision Care, the ophthalmic drug & devices market is segmented into:

  • Contact Lens
  • Spectacles
  • Eye Exams
  • Drug Testing

On the basis of Ophthalmic Drugs, the ophthalmic drug & devices market is segmented into:

  • Prescription Type
  • Drug Delivery Types
  • Type of Disease
  • Therapeutics

On the basis of End-user, the ophthalmic drug & devices market is segmented into:

  • Hospitals
  • Eye Clinics
  • Diagnostic Centers
  • Patients

Report Highlights

– The report provides a detailed analysis of the current and future market trends to identify the investment opportunities
– Market forecasts till 2026, using estimated market values as the base numbers
– Key market trends across the business segments, regions and countries
– Key developments and strategies observed in the market
– Market dynamics such as drivers, restraints, opportunities and other trends
– In-depth company profiles of key players and upcoming prominent players
– Growth prospects among the emerging nations through 2026

Companies Profiled

–        ALLERGAN INC.

–        BAYER

–        CARL ZEISS AG

–        ESSILOR INTERNATIONAL S.A.

–        GLAXOSMITHKLINE

–        JOHNSON & JOHNSON INC.

–        NOVARTIS INTERNATIONAL AG

–        PFIZER

–        ROCHE HOLDING AG

–        SANTEN PHARMACEUTICAL CO., LTD.

–        SUN PHARMACEUTICALS INDUSTRIES, LTD

–        VALENT PHARMACEUTICALS INTERNATIONAL INC.

–        ZIEMER GROUP HOLDING AG

 

Related Reports

Global veterinary diagnostic market– The global veterinary diagnostic market is anticipated to grow at a CAGR of 7.71% during the forecasting years 2019-2027.

Global neurostimulation device market The global neurostimulation device market is anticipated to grow at a CAGR of 10.01% during the forecasting years 2019 to 2027.

Alopecia (hair loss) Treatment market– The global alopecia (hair loss) treatment market is anticipated to grow at a CAGR of 5.51% between 2019 and 2027.

Media Contact
Company Name: Inkwood Research
Contact Person: Clive Cooper
Email: Send Email
Phone: 1 857-302-4704
Address:169, Harrison Avenue
City: Boston
State: Massachusetts
Country: United States
Website: https://www.inkwoodresearch.com/